| Primary |
| Migraine |
26.5% |
| Product Used For Unknown Indication |
25.5% |
| Skin Wrinkling |
8.8% |
| Torticollis |
6.5% |
| Hyperhidrosis |
4.8% |
| Muscle Spasticity |
3.8% |
| Supplementation Therapy |
3.4% |
| Blepharospasm |
2.7% |
| Hypertension |
2.6% |
| Pain |
2.5% |
| Headache |
2.0% |
| Dystonia |
1.8% |
| Blood Cholesterol Increased |
1.6% |
| Hypertonic Bladder |
1.5% |
| Asthma |
1.4% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Hypersensitivity |
1.0% |
| Nutritional Supplementation |
0.9% |
| Depression |
0.8% |
| Diabetes Mellitus |
0.8% |
|
| Drug Ineffective |
19.0% |
| Therapeutic Response Decreased |
11.4% |
| Neck Pain |
8.0% |
| Eyelid Ptosis |
6.6% |
| Muscular Weakness |
6.6% |
| Rash |
5.2% |
| Headache |
4.8% |
| Injection Site Pain |
4.8% |
| Off Label Use |
4.5% |
| Wrong Technique In Drug Usage Process |
4.2% |
| Vision Blurred |
3.8% |
| Dysphagia |
3.1% |
| Dyspnoea |
2.4% |
| Incorrect Dose Administered |
2.4% |
| Musculoskeletal Stiffness |
2.4% |
| Nausea |
2.4% |
| Speech Disorder |
2.4% |
| Swelling Face |
2.1% |
| Vomiting |
2.1% |
| Alopecia |
1.7% |
|
| Secondary |
| Product Used For Unknown Indication |
20.7% |
| Migraine |
17.5% |
| Skin Wrinkling |
17.3% |
| Muscle Spasticity |
6.9% |
| Torticollis |
6.7% |
| Supplementation Therapy |
5.7% |
| Constipation |
3.9% |
| Monoparesis |
3.6% |
| Headache |
3.0% |
| Hyperhidrosis |
2.2% |
| Blepharospasm |
2.1% |
| Hemiparesis |
1.8% |
| Fibromyalgia |
1.3% |
| Hypertension |
1.3% |
| Multiple Sclerosis |
1.2% |
| Pain |
1.0% |
| Tobacco User |
1.0% |
| Blood Cholesterol Increased |
0.9% |
| Diabetes Mellitus |
0.9% |
| Dystonia |
0.9% |
|
| Sensation Of Heaviness |
15.7% |
| Drug Ineffective |
11.4% |
| Therapeutic Response Decreased |
7.8% |
| Lethargy |
7.2% |
| Neck Pain |
6.6% |
| Off Label Use |
5.4% |
| Speech Disorder |
5.4% |
| Dysphagia |
4.2% |
| Fatigue |
4.2% |
| Dyspnoea |
3.6% |
| Erectile Dysfunction |
3.6% |
| Muscle Atrophy |
3.6% |
| Muscular Weakness |
3.6% |
| Vision Blurred |
3.6% |
| Wrong Technique In Drug Usage Process |
3.0% |
| Alopecia |
2.4% |
| Incorrect Dose Administered |
2.4% |
| Wheezing |
2.4% |
| Injection Site Pain |
1.8% |
| Injection Site Reaction |
1.8% |
|
| Concomitant |
| Hyperhidrosis |
50.0% |
| Skin Wrinkling |
50.0% |
|
|
